Literature DB >> 9651823

Repeated subcutaneous injection of staphylococcal enterotoxin B-stimulated lymphocytes retains epidermal thickness of psoriatic skin-graft onto severe combined immunodeficient mice.

T Yamamoto1, M Matsuuchi, I Katayama, K Nishioka.   

Abstract

Several approaches have recently been carried out to attempt to establish a mouse transplantation model of psoriasis. To study the effects of superantigen-driven peripheral blood mononuclear cells (PBMCs) on the persistence of psoriasiform epidermis and cytokine gene expression of the grafted psoriatic skin, staphylococcal enterotoxin B (SEB)-stimulated PBMCs (SEB-PBMCs) from psoriatic patients were subcutaneously injected once or repeatedly under the grafted full-thickness involved psoriatic skin onto severe combined immunodeficient (SCID) mice. After 5 weeks, the persistence of a psoriasiform epidermis was most distinct in mice with repeated injection of SEB-PBMCs. E-selectin expression was observed on endothelial cells in the upper dermis in mice with repeated injection of both SEB-stimulated and unstimulated PBMCs, while mice with single injection of unstimulated or SEB-PBMCs did not show positive staining. Both interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma) mRNA were detected after 5 weeks, only in mice with repeated injection of SEB-PBMCs. It is concluded that continuous supply of the activated PBMCs may help the persistence of psoriasiform architecture more clearly, and that this transplantation mouse model may serve as an in vivo model for the study of the pathogenesis and therapy of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651823     DOI: 10.1016/s0923-1811(97)00064-9

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  3 in total

1.  CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis.

Authors:  A Koreck; A Surányi; B J Szöny; A Farkas; Z Bata-Csörgö; L Kemény; A Dobozy
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 2.  Psoriasis treatment: current and emerging directed therapies.

Authors:  L S Winterfield; A Menter; K Gordon; A Gottlieb
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris.

Authors:  Lin Gao; Hong Li; Kai Li; Zhu Shen; Ling Liu; Chunying Li; Zhengdong Zhang; Yufeng Liu
Journal:  Genet Mol Biol       Date:  2009-01-10       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.